Other data also suggest that outcomes after PCI can be similar to those after CABG in diabetic patients with multivessel CHD. In one registry of 9586 patients (n = 1714 (18%) diabetes), 970 patients had multivessel disease; CABG was performed in 318 (33%), PCI in 351 (36%) and 301 (31%) were treated medically (Kapur etal., 2003). In-hospital mortality was 3% in the CABG group and 2% in the PCI group, and 1-year mortality was 7% in the CABG group, 9% in the PCI group and 10% in the medical therapy group (P = NS). The rates of repeat revascularisation at 1 year were 2% in the CABG group and 23% in the PCI group (P < 0.0001). These non-randomised data suggest that survival after PCI in the stent-era is better than previously, but the rate of recurrent ischaemic and repeat revascularisation remains high, compared with CABG.
Was this article helpful?